双碳酸食补充剂可以防止AKI
Anne C Silva Barbosa1, Katherine E Pfister1, Takuto Chiba1
1Department of Pediatrics, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.
Journal of the American Society of Nephrology : JASN
|December 4, 2023
概括
八胺酸 (DC 8) 通过增强过氧体脂肪酸氧化,保护脏免受损伤或化疗造成的损伤. 这种常见的化合物为风险患者提供了一个有前途的脏保护策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 急性损伤 (AKI) 损害了靠近管中的过氧体.
- 增加过氧体脂肪酸氧化 (FAO) 显示出脏保护作用.
- 目前还没有有效的治疗方法来准这种机制.
研究的目的:
- 调查二碳酸的脏保护潜力,特别是八二氧化酸 (DC 8).
- 为了确定DC 8是否增强过氧体FAO,并对AKI进行保护.
- 评估DC 8对脏氧体和线粒体功能的影响.
主要方法:
- 在小鼠中,食补充了二碳酸 (DC8或DC12).
- 损伤是使用缺血-再输血或西斯普拉丁模型诱导的.
- 分析包括生物化学,组织学,遗传学和蛋白质组评估.
主要成果:
- 无论是DC 8还是DC 12,都防止了AKI标志物的增加.
- 蛋白质组学揭示了DC 8保存的过氧体和线粒体蛋白质组.
- DC 8增加了过氧体FAO,并被代谢成酸盐.
结论:
- 补充八胺酸 (DC 8) 补充剂可以防止AKI.
- DC 8增强过氧体脂肪酸的氧化,并保护脏器官.
- DC 8代表了预防损伤的潜在治疗策略.
相关概念视频
Drug Elimination by Renal Route: Tubular Reabsorption
3.4K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.4K
Antihypertensive Drugs: Potassium-Sparing Diuretics
582
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
582
Renal Regulation of Acid-Base Balance
468
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
468
Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids
3.2K
Carboxylic acids, upon heating, undergo a decarboxylation reaction by releasing carbon dioxide gas. Monocarboxylic acids do not undergo decarboxylation easily. However, a silver salt of carboxylic acid reacts with bromine or iodine under high temperature to release carbon dioxide gas and forms halide with one less carbon. This reaction is called the Hunsdiecker reaction.
3.2K
Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Dialysis
322
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
322


